Frontlight ResearchEarly access
CompletedNo phase
The Application of Different Sedation Protocols in ICU Patients With Severe Pneumonia
Key facts
- Who runs it
- Xiangya Hospital of Central South University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 260 people enrolled
- Started
- 1 Feb 2023
- Ended
- 27 Jan 2025
- Type of study
- Observational, 2 groups
- Record updated
- 21 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- (1)From February 1, 2023, to December 31, 2024, diagnosed with severe pneumonia in the Respiratory Intensive Care Unit of Xiangya Hospital, Central South University. The diagnosis of severe pneumonia is based on meeting at least one major criterion or three or more minor criteria:
- Major criteria:; ①Infectious shock requiring vasopressor therapy despite adequate fluid resuscitation; ②Respiratory failure requiring tracheal intubation or mechanical ventilation
- Minor criteria:; Respiratory rate ≥ 30 breaths/min; Oxygenation index (PaO2/FiO2) ≤ 250; ③Involvement of multiple lobes; Altered mental status and/or disorientation; ⑤Blood urea nitrogen ≥ 20 mg/dl (7.14 mmol/L); ⑥Systolic blood pressure < 90 mmHg requiring aggressive fluid resuscitation. (2)Patients receiving invasive mechanical ventilation who require continuous sedation treatment; (3)Age ≥ 18 years
Who cannot take part
- Allergic to routine sedative or analgesic medications
- Patients who have not undergone sedation-agitation assessment
- Patients transferred to another hospital during treatment
- Patients who withdrew from active treatment or were discharged from the ICU within 72 hours after initiation of sedation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study collected data from patients with severe pneumonia to compare the duration of mechanical ventilation under different sedation regimens in real-world settings. It also evaluated and compared the sedation success rates, hemodynamic changes, and clinical outcomes of patients with severe pneumonia.
The 2 groups in the trial
- Cipepofol group
Initially use cipepofol as the sedative medication, with a continuous usage duration of more than 48 hours.
- Conventional group
Initially use non-cipepofol sedative medications, with a continuous usage duration of more than 48 hours.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 21 September 2026